Document is current
Any future updates will be listed below
-
Authors
Huang, Cheng
Zhu, Xiao-Dong
Shen, Ying-Hao
Wu, Dong
Ji, Yuan
Ge, Ning-Ling
Chen, Ling-Li
Tan, Chang-Jun
Zhou, Jian
Fan, Jia
Sun, Hui-Chuan http://orcid.org/0000-0003-3761-7058
-
Funding
Funding for this research was provided by:
Leading Investigator Program of the Shanghai municipal government (17XD1401100)
National Basic Research Program of China (2015CB554005)
National Natural Science Foundation of China (81871928 and 81672326, 81871929 and 82072667)
- License Information
-
More Information
Article History
Received: 29 December 2020
Accepted: 10 March 2021
First Online: 20 March 2021
Declarations
:
: The study protocol, including treatment regimen and data collection, were approved by Zhongshan Hospital Research Ethics Committee, and written informed consent was obtained from all patients before initiation of treatment.
: Consent was obtained from the patient for publication of the data shown in Fig. InternalRef removed.
: H-C S has received honorarium and lectures fees from Eisai, MSD, Bayer, AstraZeneca, Innovent, TopAlliance, Hengrui. The other authors have no conflicts of interest to declare.
